Oncolytics Biotech Inc: expects final PanCAN grant payment, more GOBLET data

What happened

• On Oct 14, 2026 the company issued a press release announcing it expects to receive the final grant payment from the Pancreatic Cancer Action Network later this quarter as part of wind-down enrollment activities in the GOBLET clinical study.
• The press release also said the company expects to report additional clinical data from GOBLET Cohort 4 and 5 over the coming months.

Key details

• Press release dated Oct 14, 2026.
• Expectation to receive the final Pancreatic Cancer Action Network grant payment later this quarter.
• Additional clinical data expected from GOBLET Cohort 4 and Cohort 5 in the coming months.

Why it may matter

• This 8-K reports Item 8.01 (Other events), which covers press releases and other events the company disclosed to the public.
• A filing does not show why the insider traded or why the company acted.